Bal Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 20, 2014, inter alia, transacted the following business:<br/><br/>- After obtaining the approvals from the members, stock exchanges and other regulatory agencies and after having received the 25% of the initial consideration amount from the subscribers, the Board has approved the issue and allotment of 13,00,000 warrants to the subscribers on preferential basis, at a conversion price of Rs.62/- per warrant.
|